Varaico: Literature-Extracted Genetic Variants

Gene:CDKN2A
Variant:p.D92N
Back to variants list

CDKN2A

NM_000077.5:p.D92N

Associated Papers

Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity.

Kimura H et al.

Biorxiv : the Preprint Server for Biology, 2025

38234851 (PubMed )
Supplement: media-2.pdf

Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment.

Yu J et al.

Frontiers in Oncology, 2025

41179686 (PubMed )
Supplement: Table3.xls › Mutations_in_after_120d_TISF

Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.

Li X et al.

Pathology, Research and Practice, 2024

Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas.

Liu G et al.

Iscience, 2023

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.

Casula M et al.

Bmc Cancer, 2019

31382929 (PubMed )
Supplement: 12885_2019_5984_MOESM1_ESM.pdf

CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.

Koulermou G et al.

Journal of Genetics, 2017

Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population.

Guan X et al.

Pigment Cell & Melanoma Research, 2013

Molecular characterization of human cutaneous melanoma-derived cell lines.

Ogbah Z et al.

Anticancer Research, 2012

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Demenais F et al.

Journal of the National Cancer Institute, 2010

The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.

Brudnik U et al.

Experimental Dermatology, 2009

CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma.

Peris K et al.

The Journal of Investigative Dermatology, 2004

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.

Byeon IJ et al.

Molecular Cell, 1998

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."